- Home
- BCRX vs CGAU Comparison
BCRX vs CGAU Comparison
Compare BCRX & CGAU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- CGAU
- Stock Information
- Founded
- BCRX 1986
- CGAU 2002
- Country
- BCRX United States
- CGAU Canada
- Employees
- BCRX N/A
- CGAU N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- CGAU Precious Metals
- Sector
- BCRX Health Care
- CGAU Basic Materials
- Exchange
- BCRX Nasdaq
- CGAU Nasdaq
- Market Cap
- BCRX 1.7B
- CGAU 1.5B
- IPO Year
- BCRX 1994
- CGAU N/A
- Fundamental
- Price
- BCRX $10.75
- CGAU $7.13
- Analyst Decision
- BCRX Buy
- CGAU Buy
- Analyst Count
- BCRX 8
- CGAU 2
- Target Price
- BCRX $16.75
- CGAU $12.00
- AVG Volume (30 Days)
- BCRX 6.8M
- CGAU 995.4K
- Earning Date
- BCRX 05-05-2025
- CGAU 05-06-2025
- Dividend Yield
- BCRX N/A
- CGAU 2.80%
- EPS Growth
- BCRX N/A
- CGAU N/A
- EPS
- BCRX N/A
- CGAU 0.18
- Revenue
- BCRX $503,485,000.00
- CGAU $1,208,123,000.00
- Revenue This Year
- BCRX $36.61
- CGAU N/A
- Revenue Next Year
- BCRX $13.19
- CGAU $8.11
- P/E Ratio
- BCRX N/A
- CGAU $33.26
- Revenue Growth
- BCRX 41.67
- CGAU 2.88
- 52 Week Low
- BCRX $5.92
- CGAU $5.41
- 52 Week High
- BCRX $11.11
- CGAU $7.82
- Technical
- Relative Strength Index (RSI)
- BCRX 64.20
- CGAU 58.83
- Support Level
- BCRX $10.46
- CGAU $6.74
- Resistance Level
- BCRX $11.00
- CGAU $7.20
- Average True Range (ATR)
- BCRX 0.41
- CGAU 0.17
- MACD
- BCRX -0.02
- CGAU 0.03
- Stochastic Oscillator
- BCRX 77.78
- CGAU 91.76
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About CGAU Centerra Gold Inc.
Centerra Gold Inc a gold mining and exploration company engaged in the operation, exploration, development, and acquisition of gold properties in Asia, North America, and other markets world-wide. The company reportable operating segments are Oksut; Mount; and Milligan Molybdenum. It derives maximum revenue from Oksut segment. Geographically, it operates in Turkey, United States, Canada and Other.